Skip to content

Survey study, 2020

Is the Japanese version of the DRSP a reliable tool for tracking PMS?

Yes. The Japanese DRSP is reliable and valid for tracking symptoms and diagnosing PMS in Japanese women, with very strong internal consistency.

Early or limited evidence 119 Japanese women

What they did

Cross-sectional study. Researchers translated the DRSP following standard guidelines, then tested it on 119 women. Women completed the questionnaire twice, 2 weeks apart, with one set during their luteal phase (second half of cycle).

What they found

The Japanese DRSP had very high internal consistency (0.93). Scores during the luteal phase correlated highly with scores on depression, PMDD, and general health questionnaires.

What it means for you

The Japanese DRSP works well for Japanese women to track their daily premenstrual symptoms. This study developed and validated a tool but did not test a treatment.

119

women tested

0.93

internal consistency coefficient

About the study

Original title
Development of a Japanese Version of the Daily Record of Severity of Problems for Diagnosing Premenstrual Syndrome
Authors
Ikeda Y, Egawa M, Hiyoshi K et al.
Journal
Women's health reports (New Rochelle, N.Y.)
Year
2020
Study design
Survey study
Participants
119
What was tested
None. This developed and validated a symptom-tracking tool.
Open access
Yes
Original abstract

Background: Premenstrual syndrome (PMS) causes physical and mental symptoms in women during the luteal phase of the menstruation cycle. To confirm the relationship between symptoms and the menstruation cycle, daily symptom records are essential for diagnosing PMS. The daily record of severity of problems (DRSP) is currently the most validated tool for tracking symptoms to confirm and scale the severity of PMS, but there has been no validated Japanese version of this instrument. We developed a Japanese version of the DRSP and assessed its psychometric properties. Methods: A Japanese version of the DRSP was developed following the translation guidelines of the latest Patient-Reported Outcomes Consortium. We conducted a computational psychometric study among 119 women, all of whom completed the Japanese version of the DRSP, the Center for Epidemiologic Studies Depression Scale (CES-D), the Premenstrual Dysphoric Disorder (PMDD) scale, and a Numerical Rating Scale (NRS) for general health status. Each was filled out twice, 2 weeks apart, so that one set was completed in the luteal phase. Results: The Japanese version of the DRSP was developed with translation and cultural adaptation. The internal consistency coefficient for the total score was 0.93. The DRSP in the luteal phase correlated highly with the CES-D, PMDD scale, and NRS for general health status. Conclusions: Our Japanese version of the DRSP, developed as a PMS/PMDD diagnostic tool, was shown to provide substantial validity and reliability to rate premenstrual symptoms for Japanese women.

Reproduced under CC-BY.

Topics